Abstract
The implementation and subsequent removal of non-pharmaceutical interventions (NPIs) during the COVID-19 pandemic significantly altered the epidemiological landscape of Mycoplasma pneumoniae (MP) in children. This study analyzes the dramatic resurgence of MP infections following the lifting of NPIs in Ningbo, China, highlighting shifts in age susceptibility, seasonality, macrolide resistance, and co-infection rates.
Introduction
During the COVID-19 pandemic, global NPIs—including mask-wearing, social distancing, and school closures—unintentionally suppressed various respiratory pathogens. Mycoplasma pneumoniae, a primary cause of community-acquired pneumonia in children, saw its transmission plummet. However, the removal of these restrictions led to a "rebound" effect, potentially driven by an "immunity gap" created by three years of reduced exposure. This paper investigates how the epidemiological characteristics of MP shifted as China transitioned into the post-pandemic era.
Methods
Researchers conducted a retrospective analysis of 10,206 children (aged 0–14) with acute respiratory tract infections at the Ningbo Medical Center LiHuiLi Hospital between January 2020 and December 2023. The study period was divided into the NPI phase (2020–2022) and the non-NPI phase (2023).
Key methodologies included:
- Pathogen Detection: PCR identification of MP and 12 other common respiratory pathogens.
- Resistance Testing: Fluorescence PCR targeting 23S rRNA mutations (positions 2,063 and 2,064) to identify Macrolide-Resistant Mycoplasma pneumoniae (MRMP).
- Statistical Modeling: Restricted Cubic Spline (RCS) regression models were used to visualize the non-linear relationship between age and infection risk.
Results
The Post-NPI Infection Surge
The transition out of the NPI phase was marked by a massive spike in MP cases. The overall positivity rate jumped from 6.35% during the NPI phase to 34.28% in 2023. This surge suggests a significant "biological debt" where a large population of children remained immunologically naive due to lack of exposure during the pandemic years.
Age-Specific Susceptibility and the "Turning Point"
Analysis of age distribution revealed that school-age children (6–14 years) remain the primary reservoir for MP. The risk of infection increases steadily with age until approximately 8 years old, which researchers identified as a critical "turning point" after which susceptibility begins to decline.
Antibiotic Resistance and Co-infection
The study documented an alarming rise in macrolide resistance, with MRMP rates increasing from 62.5% to 81.1% after NPIs were lifted. Furthermore, the rate of MP co-infection with other pathogens nearly tripled, rising from 11.2% to 30.3%. These co-infections were strongly associated with increased clinical severity and higher proportions of pneumonia cases.
Discussion
The findings underscore the profound impact of NPIs on the natural cycle of respiratory pathogens. The "immunity gap" resulted in an explosive outbreak once social distancing ended. Interestingly, while MP co-infection rates rose, the pathogen often exhibited antagonistic effects against viruses like Influenza and RSV, suggesting a competition for host resources.
The surge in MRMP is particularly concerning, likely exacerbated by the sudden increase in antibiotic use to manage the 2023 outbreak. This highlights a critical need for improved antibiotic stewardship in pediatric care.
Conclusion
The removal of NPIs triggered a significant shift in MP epidemiology in Ningbo. While the return to classic seasonality (peaking in autumn and summer) was expected, the scale of the infection surge and the rise in antibiotic resistance present new challenges for public health. Long-term, multi-center surveillance is essential to monitor these evolving trends and inform future clinical interventions.
Summary updated